Brief Introduction of China Pharmaceutical Group Company

China Pharmaceutical Group is a medical and health industrial group with the largest scale, the most complete industrial chain and the strongest comprehensive strength in China directly managed by the State-owned Assets Supervision and Administration Commission of the State Council. It focuses on distribution, retail, research and development and production of health-related products, such as preventive treatment and diagnostic care. It owns a wholly-owned or holding subsidiary of 1 1, and five listed companies, including Sinopharm Holdings, Sinopharm Holdings, Tiantan Bio, Hyundai Pharmaceutical and Consistent Pharmaceutical. From 2003 to 20 1 1 year, the average annual growth rates of the group's operating income, total profit and total assets were 33%, 44% and 35% respectively. In 20 12 years, the operating income exceeded16 billion yuan, and it is the only medical and health industry group in China that exceeds 100 billion yuan. China Pharmaceutical Group 1 is making every effort to promote the all-round development of its five platforms-modern logistics and distribution integrated operation platform, Industry-University-Research integrated scientific and technological innovation platform, national drug retail chain network, national narcotic drug distribution network, national biological product marketing and cold chain distribution network, national medical device consumable product distribution network, scientific instruments and medical devices, medical scientific research and engineering design, international operation and overseas industry of medicine, medical exhibition and media, and medical and health industry. Pharmaceutical Group has a distribution network covering 365,438+0 provinces, autonomous regions and municipalities directly under the Central Government and 30 distribution centers that meet international standards. It is the largest biomedical R&D and production enterprise in China, and has undertaken more than 80% of the production tasks of the national immunization program vaccines. The group has established production bases and medicinal materials bases for biopharmaceuticals, narcotic psychotropic drugs, anti-infective drugs, anti-tumor drugs, cardiovascular and cerebrovascular drugs and respiratory drugs, and has the strongest applied drug research institutions and engineering design institutes in China. 20 10 China pharmaceutical group was awarded as a national innovative enterprise.